Maxlinear Inc
SWB:JMX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Maxlinear Inc
SWB:JMX
|
US |
|
Mitsui Chemicals Inc
OTC:MITUF
|
JP |
|
I
|
International Consolidated Airlines Group SA
F:INR
|
UK |
|
Centene Corp
NYSE:CNC
|
US |
|
Equifax Inc
NYSE:EFX
|
US |
|
N
|
Naturgy Energy Group SA
SWB:GAN
|
ES |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
MIL:1MUV2
|
DE |
|
A
|
Active Biotech AB publ
F:BTPC
|
SE |
|
Danone SA
PAR:BN
|
FR |
|
C
|
China Petroleum & Chemical Corp
XBER:CHU
|
CN |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
LSE:0KFE
|
DE |
|
R
|
Rewalk Robotics Ltd
F:2RW
|
IL |
|
Woolworths Group Ltd
ASX:WOW
|
AU |
|
Amplitude Inc
NASDAQ:AMPL
|
US |
|
Innodata Inc
NASDAQ:INOD
|
US |
|
VICI Properties Inc
NYSE:VICI
|
US |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
T
|
Thai Beverage PCL
F:T6W
|
TH |
|
V
|
Visteon Corp
SWB:VS51
|
US |
|
Sagimet Biosciences Inc
F:0O2
|
US |
|
Synchrony Financial
NYSE:SYF
|
US |
|
Mincon Group PLC
LSE:MCON
|
IE |
|
Castle Biosciences Inc
NASDAQ:CSTL
|
US |
Wall St Price Targets
JMX Price Targets Summary
Maxlinear Inc
According to Wall Street analysts, the average 1-year price target for
JMX is 58.87 EUR with a low forecast of 23.59 EUR and a high forecast of 113.52 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JMX's stock price target?
Price Target
58.87
EUR
According to Wall Street analysts, the average 1-year price target for
JMX is 58.87 EUR with a low forecast of 23.59 EUR and a high forecast of 113.52 EUR.
What is the Revenue forecast for Maxlinear Inc?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 24%.
What is the Gross Profit forecast for Maxlinear Inc?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 27%.